{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:47:35Z","timestamp":1789832855870,"version":"4.0.1"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Glial tumors are a relatively new indication for stereotactic radiosurgery (SRS). Traditionally, SRS has been considered to be an inadequate treatment for glial tumors as these are diffuse tumors, but SRS is a highly focused treatment. Tumor delineation can be challenging given the diffuse nature of the gliomas. It has been recommended to include the T2\/fluid-attenuated inversion recovery (FLAIR) altered signal intensity areas in addition to the contrast enhancing part in the treatment plan of glioblastoma in order to increase the coverage. Some have recommended to include 5 mm margins to cover up for the diffusely infiltrative nature of the glioblastoma. The most common indication of SRS in patients with glioblastoma multiforme is tumor recurrence. SRS has also been used as a boost to the residual tumor or tumor bed after surgical excision before conventional radiotherapy. The addition of bevacizumab has been recently tried along with SRS in patients with recurrent glioblastoma to decrease radiation toxicity. Besides, SRS has also been used in patients with low-grade gliomas following recurrence. Brainstem gliomas, which are usually low-grade gliomas, are another indication for SRS. Outcomes following the use of SRS are comparable with external beam radiotherapy in brainstem gliomas, whereas the risks of radiation-induced complications is less. SRS has also been used in other glial tumors such as gangliogliomas and ependymomas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0028-3886.373633","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T04:30:03Z","timestamp":1692851403000},"page":"S207-S214","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Role of Stereotactic Radiosurgery in Glial Tumors"],"prefix":"10.4103","volume":"71","author":[{"given":"Kanwaljeet","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-29-20240907","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"key":"R2-29-20240907","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"R3-29-20240907","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1200\/JCO.2016.70.7562","article-title":"Radiation therapy for glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline","volume":"35","author":"Sulman","year":"2017","journal-title":"J Clin Oncol"},{"key":"R4-29-20240907","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"R5-29-20240907","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.nec.2020.08.007","article-title":"Radiosurgery for glioblastoma","volume":"32","author":"Bunevicius","year":"2021","journal-title":"Neurosurg Clin N Am"},{"key":"R6-29-20240907","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1200\/JCO.1992.10.9.1379","article-title":"Radiosurgery as part of the initial management of patients with malignant gliomas","volume":"10","author":"Loeffler","year":"1992","journal-title":"J Clin Oncol"},{"key":"R7-29-20240907","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0360-3016(92)90939-F","article-title":"Stereotactic radiosurgery for glioblastoma multiforme: Report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage","volume":"30","author":"Mehta","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-29-20240907","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00006123-199710000-00004","article-title":"Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms","volume":"41","author":"Kondziolka","year":"1997","journal-title":"Neurosurgery"},{"key":"R9-29-20240907","first-page":"41","article-title":"Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme","volume":"50","author":"Nwokedi","year":"2002","journal-title":"Neurosurgery"},{"key":"R10-29-20240907","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1017\/S0317167100021429","article-title":"Radiosurgery and accelerated radiotherapy for patients with glioblastoma","volume":"24","author":"Shenouda","year":"1997","journal-title":"Can J Neurol Sci"},{"key":"R11-29-20240907","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0360-3016(96)00427-0","article-title":"Gamma knife for glioma: Selection factors and survival","volume":"36","author":"Larson","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-29-20240907","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0360-3016(95)00087-F","article-title":"Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas","volume":"33","author":"Gannett","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-29-20240907","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/153303460400300105","article-title":"Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme","volume":"3","author":"Cho","year":"2004","journal-title":"Technol Cancer Res Treat"},{"key":"R14-29-20240907","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1227\/NEU.0000000000001344","article-title":"Indications and efficacy of gamma knife stereotactic radiosurgery for recurrent glioblastoma: 2 decades of institutional experience","volume":"80","author":"Imber","year":"2017","journal-title":"Neurosurgery"},{"key":"R15-29-20240907","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11060-009-9873-9","article-title":"Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma","volume":"94","author":"Pouratian","year":"2009","journal-title":"J Neurooncol"},{"key":"R16-29-20240907","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10014-010-0275-7","article-title":"Morphological and flow cytometric analysis of cell infiltration in glioblastoma: A comparison of autopsy brain and neuroimaging","volume":"27","author":"Yamahara","year":"2010","journal-title":"Brain Tumor Pathol"},{"key":"R17-29-20240907","doi-asserted-by":"crossref","first-page":"20120414","DOI":"10.1259\/bjr.20120414","article-title":"Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide","volume":"86","author":"Sherriff","year":"2013","journal-title":"Br J Radiol"},{"key":"R18-29-20240907","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3171\/2016.7.GKS161460","article-title":"Upfront boost Gamma Knife \u201cleading-edge\u201d radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: A 15-year assessment of a novel therapy","volume":"125","author":"Duma","year":"2016","journal-title":"J Neurosurg"},{"key":"R19-29-20240907","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/neuonc\/noaa019","article-title":"A phase I\/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes","volume":"22","author":"Azoulay","year":"2020","journal-title":"Neuro Oncol"},{"key":"R20-29-20240907","doi-asserted-by":"crossref","first-page":"247","DOI":"10.25259\/SNI_706_2020","article-title":"C-methionine-PET-guided Gamma Knife radiosurgery boost as adjuvant treatment for newly diagnosed glioblastomas","volume":"12","author":"Jacobo","year":"2021","journal-title":"Surg Neurol Int"},{"key":"R21-29-20240907","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000503732","article-title":"The Application of magnetic resonance imaging-deformed 11C-methionine-positron emission tomography images in stereotactic radiosurgery","volume":"97","author":"Jung","year":"2019","journal-title":"Stereotact Funct Neurosurg"},{"key":"R22-29-20240907","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11060-017-2478-9","article-title":"MGMT promoter methylation status as a prognostic factor for the outcome of gamma knife radiosurgery for recurrent glioblastoma","volume":"133","author":"Kim","year":"2017","journal-title":"J Neurooncol"},{"key":"R23-29-20240907","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/cncr.23402","article-title":"Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas","volume":"112","author":"Kong","year":"2008","journal-title":"Cancer"},{"key":"R24-29-20240907","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ijrobp.2010.12.074","article-title":"Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas","volume":"82","author":"Cuneo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-29-20240907","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11060-011-0744-9","article-title":"Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: A case-control study","volume":"107","author":"Park","year":"2012","journal-title":"J Neurooncol"},{"key":"R26-29-20240907","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000448924","article-title":"Gamma knife radiosurgery in recurrent glioblastoma","volume":"94","author":"Frischer","year":"2016","journal-title":"Stereotact Funct Neurosurg"},{"key":"R27-29-20240907","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10143-009-0212-6","article-title":"Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: A multicenter experience","volume":"32","author":"Villavicencio","year":"2009","journal-title":"Neurosurg Rev"},{"key":"R28-29-20240907","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2407-7-167","article-title":"Radiotherapeutic alternatives for previously irradiated recurrent gliomas","volume":"7","author":"Combs","year":"2007","journal-title":"BMC Cancer"},{"key":"R29-29-20240907","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0167-8140(01)00299-7","article-title":"Reirradiation of primary brain tumours: Survival, clinical response and prognostic factors","volume":"59","author":"Veninga","year":"2001","journal-title":"Radiother Oncol"},{"key":"R30-29-20240907","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00066-007-1721-2","article-title":"CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results","volume":"183","author":"Tselis","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"R31-29-20240907","doi-asserted-by":"crossref","first-page":"e002262","DOI":"10.1136\/bmjopen-2012-002262","article-title":"Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: A retrospective cohort analysis of recurrent glioblastoma multiforme","volume":"3","author":"Archavlis","year":"2013","journal-title":"BMJ Open"},{"key":"R32-29-20240907","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0360-3016(96)80017-4","article-title":"Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas","volume":"35","author":"Halligan","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R33-29-20240907","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ijrobp.2004.04.011","article-title":"Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of radiation therapy oncology group 93-05 protocol","volume":"60","author":"Souhami","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R34-29-20240907","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ijrobp.2012.01.020","article-title":"Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme","volume":"84","author":"Einstein","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R35-29-20240907","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1200\/JCO.2005.04.5963","article-title":"Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981\/22981-NCIC CE3 phase III randomized trial","volume":"24","author":"Mirimanoff","year":"2006","journal-title":"J Clin Oncol"},{"key":"R36-29-20240907","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/neuros\/nyy156","article-title":"Study protocol: Early stereotactic gamma knife radiosurgery to residual tumor after surgery of newly diagnosed glioblastoma (Gamma-GBM)","volume":"84","author":"Brehmer","year":"2019","journal-title":"Neurosurgery"},{"key":"R37-29-20240907","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jocn.2021.12.015","article-title":"The effectiveness of gamma knife radiosurgery for the management of residual high-grade gliomas: A single institutional study","volume":"95","author":"Yakar","year":"2022","journal-title":"J Clin Neurosci"},{"key":"R38-29-20240907","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000341799","article-title":"Stereotactic radiosurgery guidelines for the management of patients with intracranial dural arteriovenous fistulas","volume":"27","author":"Niranjan","year":"2013","journal-title":"Prog Neurol Surg"},{"key":"R39-29-20240907","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3171\/2018.4.JNS172909","article-title":"Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery","volume":"131","author":"Sharma","year":"2018","journal-title":"J Neurosurg"},{"key":"R40-29-20240907","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3171\/2014.11.JNS13295","article-title":"Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era","volume":"122","author":"Niranjan","year":"2015","journal-title":"J Neurosurg"},{"key":"R41-29-20240907","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10143-015-0632-4","article-title":"Factors predictive of improved overall survival following stereotactic radiosurgery for recurrent glioblastoma","volume":"38","author":"Bir","year":"2015","journal-title":"Neurosurg Rev"},{"key":"R42-29-20240907","doi-asserted-by":"crossref","first-page":"652646","DOI":"10.3389\/fonc.2021.652646","article-title":"CyberKnife for recurrent malignant gliomas: A systematic review and meta-analysis","volume":"11","author":"De Maria","year":"2021","journal-title":"Front Oncol"},{"key":"R43-29-20240907","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1200\/JCO.2008.16.3055","article-title":"Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma","volume":"27","author":"Kreisl","year":"2009","journal-title":"J Clin Oncol"},{"key":"R44-29-20240907","doi-asserted-by":"crossref","first-page":"593449","DOI":"10.3389\/fonc.2021.593449","article-title":"Bevacizumab treatment of radiation-induced brain necrosis: A systematic review","volume":"11","author":"Liao","year":"2021","journal-title":"Front Oncol"},{"key":"R45-29-20240907","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/neuros\/nyx369","article-title":"Phase I trial of radiosurgery dose escalation plus bevacizumab in patients with recurrent\/progressive glioblastoma","volume":"83","author":"Abbassy","year":"2018","journal-title":"Neurosurgery"},{"key":"R46-29-20240907","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1016\/j.wneu.2019.03.193","article-title":"Gamma knife stereotactic radiosurgery in combination with bevacizumab for recurrent glioblastoma","volume":"127","author":"Morris","year":"2019","journal-title":"World Neurosurg"},{"key":"R47-29-20240907","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.wneu.2017.02.041","article-title":"Gamma Knife radiosurgery for low-grade gliomas: Clinical results at long-term follow-up of tumor control and patients' quality of life","volume":"101","author":"Gagliardi","year":"2017","journal-title":"World Neurosurg"},{"key":"R48-29-20240907","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(05)67070-5","article-title":"Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomised trial","volume":"366","author":"van den Bent","year":"2005","journal-title":"Lancet"},{"key":"R49-29-20240907","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000209297","article-title":"Gamma knife stereotactic radiosurgery for low-grade astrocytomas","volume":"87","author":"Henderson","year":"2009","journal-title":"Stereotact Funct Neurosurg"},{"key":"R50-29-20240907","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1227\/01.neu.0000316279.22371.b8","article-title":"Gamma knife surgery for low-grade gliomas","volume":"62","author":"Heppner","year":"2008","journal-title":"Neurosurgery"},{"key":"R51-29-20240907","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00381-015-2819-y","article-title":"Gamma Knife treatment of low-grade gliomas in children","volume":"31","author":"Ek\u015fi","year":"2015","journal-title":"Childs Nerv Syst"},{"key":"R52-29-20240907","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jocn.2021.07.059","article-title":"Gamma Knife radiosurgery as salvage therapy for gangliogliomas after initial microsurgical resection","volume":"92","author":"Tuleasca","year":"2021","journal-title":"J Clin Neurosci"},{"key":"R53-29-20240907","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<555::AID-CNCR19>3.0.CO;2-3","article-title":"Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group","volume":"77","author":"Freeman","year":"1996","journal-title":"Cancer"},{"key":"R54-29-20240907","doi-asserted-by":"crossref","first-page":"103508","DOI":"10.1016\/j.critrevonc.2021.103508","article-title":"Gamma Knife radiosurgery as primary treatment of low-grade brainstem gliomas: A systematic review and metanalysis of current evidence and predictive factors","volume":"168","author":"Gagliardi","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"R55-29-20240907","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3171\/jns.2007.106.1.8","article-title":"Gamma knife surgery for focal brainstem gliomas","volume":"106","author":"Yen","year":"2007","journal-title":"J Neurosurg"},{"key":"R56-29-20240907","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00381-011-1620-9","article-title":"Gamma Knife radiosurgery as a treatment modality for low-grade pediatric brainstem gliomas: Report of two cases","volume":"28","author":"Liao","year":"2012","journal-title":"Childs Nerv Syst"},{"key":"R57-29-20240907","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3171\/2012.9.PEDS12257","article-title":"Gamma knife surgery of pediatric gliomas","volume":"10","author":"Weintraub","year":"2012","journal-title":"J Neurosurg Pediatr"},{"key":"R58-29-20240907","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00701-014-2299-y","article-title":"Gamma Knife radiosurgery for low-grade tectal gliomas","volume":"157","author":"El-Shehaby","year":"2015","journal-title":"Acta Neurochir (Wien"},{"key":"R59-29-20240907","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0360-3016(94)90061-2","article-title":"Treatment of intracranial ependymomas of children: Review of a 15-year experience","volume":"28","author":"Rousseau","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R60-29-20240907","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/1097-0142(19900801)66:3<557::AID-CNCR2820660325>3.0.CO;2-8","article-title":"Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors","volume":"66","author":"Goldwein","year":"1990","journal-title":"Cancer"},{"key":"R61-29-20240907","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000029746","article-title":"Adjuvant stereotactic radiosurgery for anaplastic ependymoma","volume":"73","author":"Jawahar","year":"1999","journal-title":"Stereotact Funct Neurosurg"},{"key":"R62-29-20240907","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/neuros\/nyy082","article-title":"Stereotactic radiosurgery for intracranial ependymomas: An international multicenter study","volume":"84","author":"Kano","year":"2019","journal-title":"Neurosurgery"},{"key":"R63-29-20240907","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1227\/01.NEU.0000338257.16220.F7","article-title":"Outcome predictors for intracranial ependymoma radiosurgery","volume":"64","author":"Kano","year":"2009","journal-title":"Neurosurgery"},{"key":"R64-29-20240907","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000493065","article-title":"Leksell radiosurgery for ependymomas and oligodendrogliomas","volume":"34","author":"Kano","year":"2019","journal-title":"Prog Neurol Surg"},{"key":"R66-29-20240907","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3171\/2008.5.17582","article-title":"Does radiosurgery have a role in the management of oligodendrogliomas?","volume":"110","author":"Kano","year":"2009","journal-title":"J Neurosurg"},{"key":"R67-29-20240907","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3171\/jns.2002.97.supplement_5.0653","article-title":"Evaluation of gamma knife radiosurgery in the treatment of oligodendrogliomas and mixed oligodendroastrocytomas","volume":"97","author":"Sarkar","year":"2002","journal-title":"J Neurosurg"}],"container-title":["Neurology India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.373633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:30:16Z","timestamp":1786725016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.373633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":66,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/0028-3886.373633","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}